Evidence map›Paper›PMID 31624939›Full record

Trial reportSurgical endoscopy2020

Safety and short-term effectiveness of endoscopic sleeve gastroplasty using overstitch: preliminary report from a multicenter study.

Manoel Galvao Neto, Rena C Moon, Luiz Gustavo de Quadros, Eduardo Grecco, Admar Concon Filho, Thiago Ferreira de Souza, Luis Augusto Mattar, Jose Americo Gomides de Sousa, Barham K Abu Dayyeh, Helmut Morais and 3 more

Abstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Surgical endoscopy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 6 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 6 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Advances and future directions in endoscopic bariatric therapies.World journal of gastrointestinal endoscopy · 2025
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Manoel Galvao NetoABC Medical School, Sao Paulo, Brazil.
Rena C MoonDepartment of Bariatric Surgery, Orlando Regional Medical Center, Orlando Health, 89 W Copeland Dr, 1st Floor, Orlando, FL, USA.
Luiz Gustavo de QuadrosABC Medical School, Sao Paulo, Brazil.
Eduardo GreccoABC Medical School, Sao Paulo, Brazil.
Admar Concon FilhoABC Medical School, Sao Paulo, Brazil.
Thiago Ferreira de SouzaABC Medical School, Sao Paulo, Brazil.
Luis Augusto MattarLEV Advanced Obesity Treatment Center, Uberlandia, Minas Gerais, Brazil.
Jose Americo Gomides de SousaLEV Advanced Obesity Treatment Center, Uberlandia, Minas Gerais, Brazil.
Barham K Abu DayyehMayo Clinic, Rochester, MN, USA.
Helmut MoraisHospital Geral de Fortaleza, Fortaleza, Ceara, Brazil.
Felipe MatzEndodiagnostic, Rio de Janeiro, Brazil.
Muhammad A JawadDepartment of Bariatric Surgery, Orlando Regional Medical Center, Orlando Health, 89 W Copeland Dr, 1st Floor, Orlando, FL, USA.
Andre F TeixeiraDepartment of Bariatric Surgery, Orlando Regional Medical Center, Orlando Health, 89 W Copeland Dr, 1st Floor, Orlando, FL, USA. andre.teixeira@orlandohealth.com.ORCID http://orcid.org/0000-0001-7650-6831
Faculdade de Medicina do ABC · BROrlando Health · USHospital Geral de Fortaleza · BRMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndoscopic sleeve gastroplasty (ESG) is an option for patients with Class I and II obesity or patients who refuse to undergo a laparoscopic bariatric surgery. The aims of this study are as follows: (1) to demonstrate a short-term outcome after primary ESG and (2) to compare the effectiveness of weight loss between Class I and Class II obesity patients.

methodsPatients undergoing ESG at four bariatric centers in Brazil between April 1, 2017 and December 31, 2018 were prospectively enrolled in the study (BMI 30.0-39.9 kg/m

resultsA total of 233 patients underwent primary ESG. The mean age and BMI of the patients were 41.1 years and 34.7 kg/m

conclusionShort-term results suggest that ESG is a safe and effective option for patients with Class I and II obesity.

Indexed as

EndoscopyAdultBariatric SurgeryBody Mass IndexBrazilFemaleGastroplastyHumansMaleObesityTime FactorsTreatment OutcomeWeight LossEffectivenessEndoscopicSafetySleeve gastroplastyWeight loss

Identifiers

PMID31624939
OpenAlexW2980707396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.